Sever Announces New Head of Global Business Development & Marketing
Sever Pharma Solutions, a leading Contract Development and Manufacturing Organization (CDMO) specializing in controlled release systems for highly potent drugs (including Implants, Vaginal Rings and Pre-filled Syringes), is pleased to announce Ulrike Foley as the new Head of Global Business Development and Marketing, effective March 10.
German-born Ulrike, known as Uli, has over 30 years of experience in business development across various pharmaceutical and CDMO organizations in the U.S. Most recently, she served as VP of Business Development at Adare/Frontida Biopharm, a pharmaceutical development and commercial contract manufacturer based in Philadelphia, U.S.
“We are delighted to welcome Uli to Sever Pharma Solutions. With her strong track record of building high-performing teams and achieving ambitious sales goals in a client-centric CDMO environment, combined with her long experience in the industry, she will be an important part of strengthening our offers and market reach,” says Kenneth Stokholm, CEO.
Ulrike Foley will be stationed in Putnam, CT.
Sever Pharma Solutions is one of the few CDMOs specializing in controlled release systems for highly potent drugs, offering end-to-end services. The company’s expertise encompasses the development of new products across various stages of development and the manufacturing of commercial products. Sever Pharma Solutions specializes in Polymer-based sustained release dosage forms such as rings and implants, aseptic Fill and Finish of High Potent drug products, and Hot Melt Extrusion as a solubility enhancement solution for poorly soluble drugs.
Total Page Views: 127
